Indeed, anti-CD47 treatment induced a significant increase of in vivo tumor cell phagocytosis by TA-MG (2.7% control versus 13.3% treated, P < 0.0001) as assessed by the presence of GFPhighRFPnegativeEBFP2+ microglia (Fig. 2 A and C). The gene discussed is CD47; the disease is neoplasm.